0 Commentarios
0 Acciones
606 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Noticias Feed
- EXPLORE
-
Páginas
-
Grupos
-
Eventos
-
Blogs
-
Marketplace
-
Foros
-
Please log in to like, share and comment!
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Commentarios 0 Acciones 580 Views 0 Vista previa
-
Are Personalized Cancer Vaccines Transforming the Future of Oncology?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value The market insights gained through this keyword market research analysis report facilitate a more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position a definite brand excellently. With the scrupulous competitor analysis covered in...0 Commentarios 0 Acciones 42 Views 0 Vista previa
-
CAR-T Cell Therapy Market Demand Rising Across Global HealthcareExpanding healthcare infrastructure in emerging economies is creating new opportunities for the CAR-T cell therapy market. Countries in Asia-Pacific and Latin America are investing in advanced cancer treatment facilities. This expansion supports global market growth. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global CAR-T Cell Therapy Market is witnessing...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Investment Trends in the Anti-cancer Drugs MarketThe increasing focus on biologics and biosimilars is transforming the anti-cancer drugs industry. These advanced therapies offer new treatment options for patients with complex cancers. Their rising adoption is expected to drive long-term market expansion. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and increasing...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Is Nanomedicine the Future of Precision Healthcare Worldwide?Executive Summary Nanomedicine Market Research: Share and Size Intelligence CAGR Value The global nanomedicine market size was valued at USD 479.30 million in 2024 and is expected to reach USD 1,247.40 million by 2032, at a CAGR of 12.70% during the forecast period This Nanomedicine Market research analysis report starts with a basic introduction...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
Is RNA-Based Therapy the Next Breakthrough in Cancer Treatment?Executive Summary RNA-Based Cancer Therapeutics Market Size and Share Across Top Segments CAGR Value The global RNA-based cancer therapeutics market size was valued at USD 415.8 million in 2025 and is expected to reach USD 947.1 million by 2033, at a CAGR of 10.80% during the forecast period Market drivers and market restraints covered in this...0 Commentarios 0 Acciones 620 Views 0 Vista previa
-
Is Synthetic Lethality the Future Breakthrough in Targeted Cancer Therapy?Executive Summary Synthetic Lethality Drug Market Size and Share Analysis Report CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market research report guides the...0 Commentarios 0 Acciones 813 Views 0 Vista previa
-
Key Trends Shaping the Future of the Bile Duct Cancer MarketBile Duct Cancer affects the bile ducts and disrupts normal digestion by blocking bile flow. It is a rare but aggressive cancer. Symptoms may include dark urine and pale stools. Bile Duct Cancer Market Overview and Growth AnalysisThe Bile Duct Cancer Market is witnessing steady expansion, driven by increasing disease prevalence, advancements in diagnostic technologies, and rising...0 Commentarios 1 Acciones 1K Views 0 Vista previa
-
Market Drivers and Challenges in the Chemotherapy-Induced Peripheral Neuropathy MarketGovernment initiatives and funding programs for cancer research are further contributing to the growth of the chemotherapy-induced peripheral neuropathy market. Increased financial support encourages the development of innovative therapies and clinical studies. The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is gaining significant attention within the global healthcare...0 Commentarios 0 Acciones 2K Views 0 Vista previa
-
Metastatic Castrate Resistant Prostate Cancer Treatment Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Metastatic Castrate Resistant Prostate Cancer Treatment Market : The global metastatic castrate resistant prostate cancer treatment market size was valued at USD 11.99 billion in 2024 and is expected to reach USD 22.37 billion by 2032, at a CAGR of 8.10% during the forecast period This Metastatic Castrate Resistant Prostate Cancer...0 Commentarios 0 Acciones 4K Views 0 Vista previa
-
Metastatic Castrate Resistant Prostate Cancer Treatment Market Leaders: Growth, Share, Value, Size, and Scope"Comprehensive Outlook on Executive Summary Metastatic Castrate Resistant Prostate Cancer Treatment Market Size and Share The global metastatic castrate resistant prostate cancer treatment market size was valued at USD 11.99 billion in 2024 and is expected to reach USD 22.37 billion by 2032, at a CAGR of 8.10% during the forecast period The insights...0 Commentarios 0 Acciones 1K Views 0 Vista previa
-
What Are the Latest Innovations in Hodgkin Lymphoma Drug Market?Market Trends Shaping Executive Summary Hodgkin Lymphoma Drug Market Size and Share CAGR Value Data Bridge Market Research analyses that the Hodgkin lymphoma drug will exhibit a CAGR of around 14.75% for the forecast period of 2022-2029 This Hodgkin Lymphoma Drug Market report covers a myriad of aspects of the market analysis that many businesses call for. This market report comprises...0 Commentarios 0 Acciones 308 Views 0 Vista previa
Resultados de la búsqueda
Patrocinados
Patrocinados
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek